Edward A Gill
Overview
Explore the profile of Edward A Gill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang G, Sheehan F, Gill E
Echocardiography
. 2021 Dec;
39(1):89-100.
PMID: 34913188
Transesophageal echocardiography (TEE) has experienced tremendous increase in interest and demand alongside the rapid growth of transcatheter structural cardiac interventions. TEE instruction prolongs the procedure, increasing the risk of probe...
12.
Taskesen T, Gill E
Echocardiography
. 2021 Feb;
39(7):1001-1009.
PMID: 33604936
The pulmonary valve (PV) has historically been ignored by imaging studies. Disorders of the PV encountered in adult cardiac patients are increasingly encountered due to advanced care of patients with...
13.
Orringer C, Blaha M, Blankstein R, Budoff M, Goldberg R, Gill E, et al.
J Clin Lipidol
. 2021 Jan;
15(1):33-60.
PMID: 33419719
An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for adults seen for primary prevention...
14.
Robinson J, Jayanna M, Brown A, Aspry K, Orringer C, Gill E, et al.
J Clin Lipidol
. 2019 Jul;
13(4):525-537.
PMID: 31281070
Acquisition costs and cost-effectiveness have limited access and recommendations to use proprotein convertase subtilisin/kexin type 9 (PCSK9)-inhibiting monoclonal antibodies (mAbs). Recently, prices were reduced by 60% for alirocumab and evolocumab....
15.
Taskesen T, Prabhu S, Steinberg Z, Oxorn D, Gill E
Echocardiography
. 2019 Apr;
36(5):930-937.
PMID: 31002189
Background: The present study designed to evaluate feasibility of transesophageal echocardiographic (TEE) imaging of the pulmonary valve (PV) at the transaortic upper esophageal (TAUE) window. We hypothesized that patients with...
16.
Donmez E, Salcedo E, Quaife R, Burke J, Gill E, Carroll J
Echocardiography
. 2019 Feb;
36(4):732-741.
PMID: 30801804
Background: The effects of edge-to-edge percutaneous mitral valve repair on the shape and size of the mitral annulus and its relation to mitral regurgitation (MR) have not been well characterized....
17.
Gill E, Blaha M, Guyton J
J Clin Lipidol
. 2019 Feb;
13(1):4-14.
PMID: 30773212
Computed tomographic (CT) coronary calcium scoring has been established by large prospective, population-based studies as the single best noninvasive predictor of atherosclerotic cardiovascular risk available today. The calcium score correlates...
18.
Bristow M, Kao D, Breathett K, Altman N, Gorcsan 3rd J, Gill E, et al.
JACC Heart Fail
. 2017 Nov;
5(11):772-781.
PMID: 29096787
Diagnosis, prognosis, treatment, and development of new therapies for diseases or syndromes depend on a reliable means of identifying phenotypes associated with distinct predictive probabilities for these various objectives. Left...
19.
P Phan B, Bahrainy S, Gill E
J Clin Lipidol
. 2016 May;
10(3):469-71.
PMID: 27206933
No abstract available.
20.
Herrick C, Bahrainy S, Gill E
Endocrinol Metab Clin North Am
. 2016 Feb;
45(1):117-28.
PMID: 26893001
Lipid lowering, particularly with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ("statins"), reduces the risk of cardiovascular disease. Patients with chronic liver disease present challenges to the use of lipid medications. In the...